Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy.

ABSTRACT: About 70% of people with osteogenesis imperfecta (OI) experience hearing loss. There is no cure for OI, and therapies to ameliorate hearing loss rely on conventional treatments for auditory impairments in the general population. The success rate of these treatments in the OI population with poor collagenous tissues is still unclear. Here, we conduct a systematic review and meta-analysis on the efficacy of treatments addressing hearing loss in OI. This study conforms to the reporting standards of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). Data sources include published articles in Medline via PubMed, Web of Science, Scopus, and Embase, from their inception to November 2020. Studies included individuals with OI undergoing a hearing loss treatment, having

SUBMITTER: Ugarteburu M 

PROVIDER: S-EPMC9556526 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature